S. Buglioni

Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma.

E. Pescarmona, S. Rodig, M. Fanciulli, 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

Small molecules targeted to the microtubule–Hec1 interaction inhibit cancer cell growth through microtubule stabilization

D. Trisciuoglio, E. Cundari, A. Brancale, 2017, Oncogene.

KRAS G12C mutation and risk of disease recurrence in stage I surgically resected lung adenocarcinoma.

G. Ciliberto, F. Cappuzzo, P. Visca, 2023, Lung cancer.